UNSPSC 51261701: Arnolol
Commodity
Code facts
- Part of
-
-
51000000
-
51260000
- 51261700
-
51260000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51261701
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98HS077RUP, chemically known as 2-butanol, 3-amino-1-(4-(2-methoxyethyl)phenoxy)-3-methyl- but generally known as arnolol, which bears US NIH Compound Identifier 65653. European Medicines Agency schedules Arnolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05565MIG.
Read the full definition
The term ARNOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). ARNOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arnolol under HS 29221980 and SITC 51461. As of Q4 2014, ARNOLOL remains the US FDA Preferred Term for this commodity. Arnolol bears US NLM identifiers UMLS ID C0641873 and NCI Concept Code C73015. SMILES: OC(C(N)(C)C)COC1CCC(CCOC)CC1.
About UNSPSC 51261701
UNSPSC 51261701 Arnolol is a Commodity code under which state and local governments procure naloxone and related opioid-response pharmaceuticals and drug deactivation systems to support community health and overdose-prevention initiatives. Recent solicitations show state and local health agencies buying finished naloxone units and safe drug deactivation systems in bulk quantities, typically through competitive sealed-bid processes with annual volume commitments and quarterly or routine delivery schedules. Issuing bodies include county health departments and state health and human services agencies. The scope reflects direct pharmaceutical procurement tied to public health emergency response and substance-abuse prevention programs rather than raw chemical ingredients or laboratory compounds.
Recent activity appears concentrated in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's community health building in Sanford, with bids due July 26, 2023, and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 exploring vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program, though that RFI targets broader pharmacy benefit management strategy rather than naloxone procurement specifically. The Seminole County IFB is the clearer match to the commodity scope. No explicit set-aside or disadvantaged-enterprise designations appear in either opportunity. Both jurisdictions require E-Verify compliance and standard insurance coverage; the Seminole County bid included potential FEMA funding with associated federal compliance obligations.
Quick answers
What is UNSPSC 51261701?
UNSPSC 51261701 is Arnolol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51261701?
UNSPSC 51261701 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51261701
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code